- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Actor Jeremy Pope joins ViiV's 'PrEP Wisdom' campaign to educate on long-acting PrEP options | ||
| Fr | Moderna's COVID vaccine carries stellar Q3 revenue beat | ||
| Fr | Fierce Pharma Asia-Boehringer's $7.4B SBP deal; Fresenius' sweeping biosim pact; A $1B molecular glue bet | ||
| Fr | Novartis confirms more reported tumor cases in Zolgensma patients as SMA groups seek details | ||
| 05.11. | ANI makes $560M play for Egetis and its approved orphan drug Emcitate | ||
| 05.11. | RevMed's Rasonque debut nets 'eye-popping' $198M in 5 weeks, even as exec tempers expectations | ||
| 05.11. | Boehringer Ingelheim brings liver health education push to the NASCAR fast lane | ||
| 05.11. | AstraZeneca said to offer $10B to acquire Rhythm, analysts whisper of a bidding war | ||
| 05.11. | VintaBio assets go on auction block as CGT viral vector demand slows | ||
| 05.11. | Alnylam seeks new commercial leader as Tolga Tanguler exits amid faltering Amvuttra trajectory | ||
| 04.11. | With oncology pipeline at 'inflection point,' Merck puts finish line in focus with new corporate campaign | ||
| 04.11. | Sanofi runs emotive RSV campaign zeroing in on a baby's bronchiolitis breathing sounds | ||
| 04.11. | Novo catches Wegovy pill tailwind in Q3 as CEO eyes new launch horizons in 2027 | ||
| 04.11. | Madrigal's former clinical development head files whistleblower lawsuit alleging Rezdiffra safety cover-up | ||
| 04.11. | Samsung Bio union vows strike as labor negotiations stall | ||
| 04.11. | BMS Canada teams with TANK Worldwide, Ogilvy Health to turn autumn leaves into melanoma awareness campaign | ||
| 04.11. | Rising Stars: Publicis Health's Ariel Rabinowitz knows what it takes to 'meet people where they are' | ||
| 03.11. | Amgen's quality chief to retire as internal successor steps up | ||
| 03.11. | Madrigal's Rezdiffra storms past blockbuster milestone as CEO hails 'accelerating' MASH market | ||
| 03.11. | Pfizer delivers Q3 beat as post-COVID comeback gains momentum | ||
| 03.11. | As Bayer spots pharma recovery, questions resurface over potential crop science split | ||
| 03.11. | Lonza bets big on US growth, snaps up Merck KGaA's CDMO business | ||
| 02.11. | Sumitomo's Gemtesa power couple takes the wheel in road-trip themed overactive bladder awareness push | ||
| 02.11. | Hansoh, Samsung Biologics hit with FDA write-ups after inspections | ||
| 02.11. | Inovio's DNA-based immunotherapy Voceryq approved by FDA for rare HPV airway disease |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.